There are 699 resources available
273P - Pathological complete response following pre-operative chemoradiotherapy in locally advanced rectal cancer: An institutional analysis
Presenter: Mehmet Duymaz
Session: Poster Display session
274P - Utility of MRI-based radiomic metrics and circulating tumor DNA to predict outcomes in locally advanced rectal cancer
Presenter: Alessandro Passardi
Session: Poster Display session
275P - Lower CD11c-expression in tumor stroma indicates poor prognosis in rectal cancer patients
Presenter: Rosa-Maria Penttinen
Session: Poster Display session
276TiP - Intraoperative electron radiotherapy in rectal cancer (ELECTRA): A feasibility trial
Presenter: Sean Ewings
Session: Poster Display session
277TiP - Total neoadjuvant therapy and organ preservation versus surgery for rectal cancer prospective, non-inferiority, randomized, controlled trial (STart)
Presenter: Ernestas Šileika
Session: Poster Display session
281P - Comparison of efficacy & safety of two frontline cytotoxic chemotherapy regimens in newly diagnosed metastatic cancer of biliary tract: A randomized control study
Presenter: nishant sinha
Session: Poster Display session
282P - Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer
Presenter: Oliver Klein
Session: Poster Display session
283P - Postoperative adjuvant tislelizumab plus lenvatinib and capecitabine for biliary tract cancer: Interim results of a prospective, single-arm, phase II study
Presenter: Yun Feng
Session: Poster Display session
284P - Efficacy and safety of stereotactic body radiation therapy combined with surufatinib and sintilimab for patients with biliary tract cancer failed with standard therapy
Presenter: Ai Huang
Session: Poster Display session
285P - Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial
Presenter: Lorenza Rimassa
Session: Poster Display session